Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Delpazolid by LigaChem Biosciences for Mycobacterium Infections: Likelihood of Approval
Delpazolid is under clinical development by LigaChem Biosciences and currently in Phase II for Mycobacterium Infections. According to GlobalData, Phase...